General Funding for Preclinical Development of Countermeasures Against Select Pathogens Originally published on Global Defense A new funding opportunity from the National Institute of Allergy and Infectious Diseases (NIAID), Partnerships for Countermeasures Against Select Pathogens, will support preclinical development of lead candidate therapeutics, vaccines, and related countermeasures against select emerging infectious diseases and pathogens, including coronavirus. The call for proposals encourages a broad array of preclinical activities […] Written by Staff Writer June 19, 2020October 11, 2021